BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Arrowhead buys Novartis' RNAi assets, page-6

  1. Maxineamillion
    2,381 Posts.
    lightbulb Created with Sketch. 10
    clock Created with Sketch.
    06/03/15
    18:37
    Post #: 14874450
    So, Novartis think that Alnylam's patents are worth $10 million, and the market thinks Alnylam are worth $10 billion.

    Kind of proves that the foundation patents don't matter anymore.
    BLT Price at posting: 83.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
FWD Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.